Ferozsons Laboratories shareholders approve FY2026 audited statements and Rs. 5.5 per-share final dividend
AGM / EGMExtract of resolutions passed at Ferozsons Laboratories Limited’s 70th Annual General Meeting held on October 28, 2026. Shareholders approved the FY2026 audited financial statements and a final cash dividend of 55% (Rs. 5.5 per share), reappointed KPMG Taseer Hadi & Co. as auditors for FY2027, and ratified related-party transactions.
Payout
- Final cash dividend Rs 5.50 per share (55%)
Key Findings
- The 70th Annual General Meeting was held on October 28, 2026.
- Minutes of the Extraordinary General Meeting held on July 3, 2026 were confirmed and approved.
- The audited financial statements for the year ended June 30, 2026 were adopted.
- A final cash dividend of 55%, equivalent to Rs. 5.5 per share, was approved for the year ended June 30, 2026.
- KPMG Taseer Hadi & Co. was reappointed as external auditor for the year ending June 30, 2027; related-party transactions were ratified and future transactions authorized subject to Board approval.
Meeting Details
Meeting
Annual general meeting
Date
28/10/2026
Meeting Details
Agenda
- Confirmation of minutes of the Extraordinary General Meeting held on July 3, 2026
- Adoption of audited financial statements for the year ended June 30, 2026
- Approval of final cash dividend for the year ended June 30, 2026
- Appointment of auditors for the year ending June 30, 2027 and fixation of remuneration
- Ratification of related-party transactions and authorization for future related-party transactions
Resolutions
- Confirmed and approved the minutes of the Extraordinary General Meeting held on July 3, 2026.
- Received, considered and adopted the audited financial statements for the year ended June 30, 2026, together with the Chairperson’s Review, Directors’ Report and Auditors’ Reports.
- Approved a final cash dividend at 55% (Rs. 5.5 per share) for the year ended June 30, 2026.
- Reappointed KPMG Taseer Hadi & Co. as external auditors for the year ending June 30, 2027, on remuneration recommended and approved by the Board.
- Ratified and confirmed related-party transactions disclosed in note 39 of the unconsolidated financial statements for the year ended June 30, 2026, and authorized future related-party transactions as approved by the Board.
⚡
Highlights summarize the key points from the company's official PSX filing. View the original filing for the complete details before making financial decisions.

